Related Experiment Video
Updated: Jun 1, 2026
08:30
Paradigms for Behavioral Assessment in Drosophila Model of Autism Spectrum Disorder
Published on: September 6, 2024
Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders
Christian P Schaaf1, Aniko Sabo, Yasunari Sakai
1Department of Molecular and Human Genetics, Program in Developmental Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Human Molecular Genetics
|June 1, 2011
Summary
Researchers identified de novo mutations in 1.8% of individuals with idiopathic autism spectrum disorder (ASD). Oligogenic heterozygosity, a combination of multiple gene variants, was observed in 6.8% of ASD cases, suggesting a novel role in autism pathogenesis.
Area of Science:
- Neurodevelopmental disorders
- Genetics of Autism Spectrum Disorder (ASD)
- Molecular pathogenesis
Background:
- Autism spectrum disorders (ASDs) are complex neurodevelopmental conditions with a heterogeneous etiology.
- While genetic factors for syndromic autism are increasingly identified, the causes of idiopathic non-syndromic autism remain largely unknown.
- Understanding the genetic underpinnings of idiopathic ASD is crucial for diagnosis and therapeutic development.
Purpose of the Study:
- To investigate the role of de novo mutations in known autism susceptibility genes in idiopathic ASD.
- To explore the potential contribution of oligogenic heterozygosity to the pathogenesis of ASD.
- To compare the frequency of oligogenic heterozygosity in ASD patients versus a control population.
Main Methods:
- Sanger sequencing was employed to analyze 21 known autism susceptibility genes in 339 individuals with high-functioning, idiopathic ASD.
- De novo mutations and instances of oligogenic heterozygosity were identified in the patient cohort.
- A control population was screened for novel coding variants in specific genes (CACNA1C, CDKL5, HOXA1, SHANK3, TSC1, TSC2, UBE3A) to assess oligogenic heterozygosity rates.
Main Results:
- De novo mutations were detected in at least one of the studied genes in 1.8% of the ASD probands.
- Oligogenic heterozygosity was identified in 6.8% of the ASD cohort.
- The rate of oligogenic heterozygous events was significantly lower in the control population (P < 0.01), supporting its association with ASD.
Conclusions:
- De novo mutations in known autism genes contribute to a small fraction of idiopathic ASD cases.
- Oligogenic heterozygosity emerges as a potential novel mechanism contributing to the pathogenesis of autism spectrum disorders.
- Further research into complex genetic interactions, such as oligogenic heterozygosity, is warranted for a comprehensive understanding of ASD etiology.
Related Concept Videos
01:11Genetic Lingo
Overview
01:19Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:35Pedigree Analysis
Overview
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:25Genetic Variation
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles, which...
Genes exist in different versions called alleles, which...